Related Experiment Video

Updated: May 14, 2026

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice
09:29

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice

Published on: June 11, 2020

Treatment of neonatal seizures

Linda G M van Rooij1, Lena Hellström-Westas, Linda S de Vries

  • 1Department of Neonatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, The Netherlands.

Seminars in Fetal & Neonatal Medicine
|February 14, 2013
PubMed

Insights

Neonatal seizures are common but challenging to diagnose and treat. Current treatments are often ineffective, highlighting the need for better therapies and research into neonatal seizure management.

Area of Science:

  • Neonatal neurology
  • Pediatric epilepsy
  • Clinical pharmacology

Background:

  • Neonatal seizures are the most frequent seizure type across the lifespan.
  • The incidence of neonatal seizures varies based on diagnostic criteria and study populations.
  • Debate continues regarding whether seizures cause brain damage or result from underlying conditions.

Purpose of the Study:

  • To review current knowledge on treating neonatal seizures in term and preterm infants.
  • To highlight the limitations of existing therapeutic options.
  • To emphasize the need for rigorous clinical trials on novel antiepileptic drugs.

Main Methods:

  • Literature review of studies on neonatal seizure treatment.
  • Analysis of current therapeutic strategies and their efficacy.
  • Identification of gaps in evidence regarding treatment efficacy and safety.

Main Results:

  • First-generation antiepileptic drugs show limited effectiveness in neonatal seizure management.
  • There is a lack of consensus on optimal treatment protocols and efficacy assessment.
  • Subclinical seizures also present diagnostic and therapeutic challenges.

Conclusions:

  • Effective treatment for neonatal seizures remains a significant clinical challenge.
  • Prospective, randomized, controlled trials are crucial for evaluating second-generation antiepileptic drugs.
  • Further research is urgently needed to improve outcomes for infants experiencing seizures.

Keywords:
Antiepileptic drugsNeonatal seizuresTreatment

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Recording EEG in Freely Moving Neonatal Rats Using a Novel Method08:03

Recording EEG in Freely Moving Neonatal Rats Using a Novel Method

Published on: May 29, 2017

Related Concept Videos

Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...